What's Happening?
Plexāā, a medtech company, has introduced the BLOOM43 platform in the U.S. to coincide with Breast Cancer Awareness Month. This platform includes a wearable preconditioning medical device and a companion app designed to prepare patients for breast surgery. The BLOOM43 device is non-invasive and drug-free, intended for use at home before surgery. It employs Supraphysiological Preconditioning™, a technique that heats the skin to stimulate blood flow and release heat shock proteins, reducing the risk of skin necrosis and the need for follow-up surgeries. The companion app offers a comprehensive Prehab™ program, providing guidance on nutrition, physical health, and community support. The device is available for prescription in the U.S., and the app is accessible globally.
Why It's Important?
The introduction of the BLOOM43 platform addresses a significant gap in pre-surgical preparation, as many patients feel unprepared for breast surgery. By enhancing tissue health before surgery, the device aims to reduce complications, hospital stays, and healthcare costs. This innovation could significantly impact the healthcare industry by improving surgical outcomes and patient empowerment. It also highlights the growing trend of integrating technology with healthcare to provide personalized and effective patient care solutions.
What's Next?
The BLOOM43 device is now available for prescription, and its adoption by hospitals and clinics across the U.S. is expected to grow. As more patients and healthcare providers become aware of its benefits, the platform could see widespread use, potentially influencing future surgical preparation protocols. The success of this launch may encourage further innovations in pre-surgical care and the development of similar technologies for other types of surgeries.
